Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost

By Covert David   Robin Alan L.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 971-976

Informa Healthcare

Access to resources Recommend Favorite

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma

By Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1875-1883

Informa Healthcare

Access to resources Recommend Favorite

The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

By Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 897-905

Informa Healthcare

Access to resources Recommend Favorite

A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy

By Christensen Torsten Lundgaard   Poulsen Peter Bo   Holmstrom Stefan   Walt John G.   Vetrugno Michele  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1837-1844

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

By Martinez Antonio   Sanchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1025-1032

Informa Healthcare

Access to resources Recommend Favorite